Activity value 72china Supplier,Last transaction date:
2026-03-15
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hangzhou zhongmeihuadong pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 9 transactions, with a transaction quantity of 4462 and a transaction weight of 14886.
Product description
PHENOL WORKING STANDARD 200 MG X 5 VIALS 1000 MG FOR R &D PURPOSE ONLY PHENOL WORKING STANDARD 200 MG X 5 VIALS 1000 MG FOR R &
Expand
Product description
METACRESOL WORKING STANDARD 100 MG X 10 VIALS 1000 MG FOR R & D PURPOSE ONLY METACRESOL WORKING STANDARD 100 MG X 10 VIALS 1000 MG FO
Expand
Product description
INSULIN DEGLUDEC INJECTION PLACEBO REFERENCE STANDARD FOC 10 ML X 20 VIALS 200 ML VALUE FOR CUSTOM PURPOSE ONLY INSULIN DEGLUDEC INJECTION PLACEBO REFERENCE STANDARD FOC
Expand
Product description
INSULIN DEGLUDEC WORKING STANDARD 60 MG X 17 VIALS 1020 MG FOR R & D PURPOSE ONLY INSULIN DEGLUDEC WORKING STANDARD 60 MG X 17 VIALS 1020 MG
Expand
Product description
INSULIN ASPART WORKING STANDARD 100 MG X 10 VIALS 1000 MG FOR R & D PURPOSE ONLY INSULIN DEGLUDEC WORKING STANDARD 100 MG X 10 VIALS 1000 M
Expand
Product description
INSULIN DEGLUDEC AND INSULIN ASPART INJECTION 70 30 INJECTION 100 UNITS ML 1500 CARTRIDGE FOR R & D PURPOSE ONINSULIN DEGLUDEC AND INSULIN ASPART INJECTION 70 30 INJECT
Expand
Trade date
2025/11/29
B/L No.
——
Suppliers
hangzhou zhongmeihuadong pharma
Buyers
.laurus synthesis inc.
5ао фармасинтез
russiasupplier,they trade on 2021-03-01
33.13%
>
+View All
Products
Total 53
ProductsTransactionsPerDetail
semaglutide 1645.71%>
bat 822.86%>
pharmaceutical 514.29%>
ice 514.29%>
ion 514.29%>
+View All
Hscode rank
Total 22
HSCode NameTransactionsPerDetail
HS 293719001234.29%>
HS 980200001131.43%>
HS 2941909025.71%>
HS 2934999025.71%>
HS 2932999012.86%>
+View All
Trading Area
Total 11
AreaTransactionsPerDetail
india3536.46%>
vietnam1818.75%>
paraguay1313.54%>
pakistan88.33%>
united states77.29%>
+View All
Port statistics
Total 10
Port NameTransactionsPerDetail
hangzhou55.21%>
hangzhou cn55.21%>
57035, shanghai33.13%>
bangkok22.08%>
shanghai22.08%>
+View All
hangzhou zhongmeihuadong pharma is china Supplier,
and primarily engages in the import and export business of products such as semaglutide,bat,pharmaceutical.
According to the 52wmb.com global trade database, as of 2026-03-15, the company has completed 96 international trades,
with its main trading regions covering india,vietnam,paraguay etc.
The core products include HS29371900,HS98020000,HS29419090 etc,
often transported via hangzhou,port hangzhou cn, port 57035, shanghai etc,
and its main trading partners are dr reddy s laborotoies inc.,prosalud farma s.a.,.merap group corp..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hangzhou zhongmeihuadong pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.